SuperworthArbutus Biopharma shares outstanding ABUS
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 197.5M
- On a year earlier
- +2.6%
- more shares
Arbutus Biopharma had 197.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 192.3M | +1% |
| FY2024 | 189.7M | +13% |
| FY2023 | 168.6M | +8% |
| FY2022 | 155.5M | +17% |
| FY2021 | 133.2M | +54% |
| FY2020 | 86.2M | +46% |
| FY2019 | 58.9M | +6% |
| FY2018 | 55.5M | +1% |
| FY2017 | 55.1M | +1% |
| FY2016 | 54.5M | +7% |
| FY2015 | 51M | +128% |
| FY2014 | 22.4M | +25% |
| FY2013 | 17.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 197.5M | +3% | |
| Q1 FY26 | 195.2M | +2% | |
| Q4 FY25 | 192.3M | +1% | |
| Q3 FY25 | 191.8M | +1% | |
| Q2 FY25 | 192.4M | +2% | |
| Q1 FY25 | 190.7M | +9% | |
| Q4 FY24 | 189.7M | +13% | |
| Q3 FY24 | 189M | +13% | |
| Q2 FY24 | 188M | +13% | |
| Q1 FY24 | 175.6M | +9% | |
| Q4 FY23 | 168.6M | +8% | |
| Q3 FY23 | 167.5M | +11% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Arbutus Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.